HORIZON-MISS-2022-CANCER-01
HORIZON-MISS-2022-CANCER-01
- Programme
- HORIZON
- Funded projects (dataset)
- 20
- EU contribution (sum)
- €123,757,922
- Portal deadline
- —
Leading topic in historical projects: HORIZON-MISS-2022-CANCER-01-03
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- EORTC3 coordinated
- AICIB1 coordinated
- UNIBO1 coordinated
- CENTRE FOR INNOVATION IN MEDICINE1 coordinated
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN1 coordinated
- IMIM1 coordinated
- UOA1 coordinated
- CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS CERTH1 coordinated
- FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE1 coordinated
- HOSPICES CIVILS DE LYON1 coordinated
- .1 coordinated
- ICO1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 4 shared
- 4 shared
- 3 shared
- 3 shared
- HUS · TARTU UNIVERSITY HOSPITAL3 shared
FI ↔ EE
- HUS · NATIONAL CANCER INSTITUTE3 shared
FI ↔ LT
- 3 shared
- 3 shared
- KI · NATIONAL CANCER INSTITUTE3 shared
SE ↔ LT
- 3 shared
- 3 shared
- 3 shared
- 3 shared
- 3 shared
- 3 shared
- 3 shared
- KI · TARTU UNIVERSITY HOSPITAL3 shared
SE ↔ EE
- 3 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 20.25
- Median orgs / project
- 17
- Min / max orgs
- 5 – 62
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Spain57
- Italy37
- Belgium32
- France29
- Germany24
- Greece24
- Sweden23
- Romania17
- Netherlands17
- Lithuania13
- Norway10
- Ireland9
- Czechia9
- Austria8
- Portugal8
- Hungary7
- Poland7
- Slovakia6
Organization types
- research_institute98 orgs · 146 rows
- university56 orgs · 74 rows
- other61 orgs · 69 rows
- public_body46 orgs · 61 rows
- sme32 orgs · 35 rows
- company20 orgs · 20 rows
Topics in funded projects
- HORIZON-MISS-2022-CANCER-01-03HORIZON-MISS-2022-CANCER-01-03· 12 projects
- HORIZON-MISS-2022-CANCER-01-01HORIZON-MISS-2022-CANCER-01-01· 6 projects
- HORIZON-MISS-2022-CANCER-01-02HORIZON-MISS-2022-CANCER-01-02· 1 projects
- HORIZON-MISS-2022-CANCER-01-05HORIZON-MISS-2022-CANCER-01-05· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| CCI4EU COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE | HORIZON | €9,984,080 |
| ONCODIR ONCODIR – Evidence-based Participatory Decision Making for Cancer Prevention through implementation research | HORIZON | €7,893,636 |
| PREVENT Improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research - the PREVENT approach | HORIZON | €7,469,250 |
| DE-ESCALATE INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL | HORIZON | €7,185,663 |
| PIECES TOWARDS LARGE-SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE-BASED PRIMARY CANCER PREVENTION PROGRAMMES IN EUROPE AND BEYOND | HORIZON | €6,930,111 |
| SALVOVAR A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES | HORIZON | €6,823,071 |
| LIVERATION Unravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence? | HORIZON | €6,578,064 |
| IntReALL 2020 International Study for Treatment of Childhood Relapsed ALL 2020 | HORIZON | €6,135,176 |
| ECHoS Establishing of Cancer Mission Hubs: Networks and Synergies | HORIZON | €6,096,148 |
| Sagittarius A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL | HORIZON | €5,999,765 |
| PragmaTIL Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors | HORIZON | €5,998,840 |
| IMPACT- AML Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia | HORIZON | €5,988,403 |
| PRIME-ROSE PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials | HORIZON | €5,968,725 |
| CPW Cancer Prevention at Work (CPW): Occupational health surveillance in the implementation of prevention of infection-related cancer. | HORIZON | €5,801,578 |
| CARE1 First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma | HORIZON | €5,577,694 |